These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21934080)

  • 1. Informed consent in cardiac resynchronization therapy: what should be said?
    Kramer DB; Brock DW; Tedrow UB
    Circ Cardiovasc Qual Outcomes; 2011 Sep; 4(5):573-7. PubMed ID: 21934080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social restrictions on informed consent: research ethics and medical decision making.
    May T
    HEC Forum; 2004 Mar; 16(1):38-44. PubMed ID: 15181669
    [No Abstract]   [Full Text] [Related]  

  • 3. Trends amongst implantable cardioverter defibrillator patients in a tertiary cardiac centre in Singapore from 2002 to 2011.
    Chong DT; Tan BY; Ho KL; Teo WS; Ching CK
    Ann Acad Med Singap; 2013 Sep; 42(9):480-2. PubMed ID: 24162324
    [No Abstract]   [Full Text] [Related]  

  • 4. Resynchronization therapy in heart failure: the 'nonresponder'.
    Sinagra G; Proclemer A; Zecchin M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e112-e115. PubMed ID: 29538157
    [No Abstract]   [Full Text] [Related]  

  • 5. [European Society of Cardiology guidelines on cardiac resynchronization therapy].
    Robinet S; Delcour A; Lancellotti P;
    Rev Med Liege; 2014 Apr; 69(4):180-7. PubMed ID: 24923097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cardiac resynchronization therapy on quality of life: the best gets the least.
    Botto GL; Russo G
    Europace; 2012 Nov; 14(11):1537-9. PubMed ID: 23099426
    [No Abstract]   [Full Text] [Related]  

  • 7. Can nuclear cardiology optimize cardiac resynchronization therapy lead placement: Paving the way to precision medicine?
    Kerr N; Miller RJH; Chew DS
    J Nucl Cardiol; 2024 Jun; 36():101873. PubMed ID: 38704017
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of Frailty Assessment for Elderly Patients Undergoing Cardiac Resynchronization Therapy.
    Kubala M; Guédon-Moreau L; Anselme F; Klug D; Bertaina G; Traullé S; Buiciuc O; Savouré A; Diouf M; Hermida JS
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1523-1533. PubMed ID: 29759834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitachycardia and resynchronization devices in the treatment of heart failure and prevention of sudden death].
    Sapel'nikov OV; Latypov RS; Grishin IR; Mareev IuV; Saidova MA; Akchurin RS
    Kardiologiia; 2011; 51(9):60-7. PubMed ID: 21943010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Implantable Electronic Device Therapy in Heart Failure.
    Hussein AA; Wilkoff BL
    Circ Res; 2019 May; 124(11):1584-1597. PubMed ID: 31120815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Resynchronization Therapy and Implantable Cardioverter Defibrillator Therapy in Advanced Heart Failure.
    Choi AJ; Thomas SS; Singh JP
    Heart Fail Clin; 2016 Jul; 12(3):423-36. PubMed ID: 27371518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRT or CRT-D devices? The case for 'high energy' devices.
    Saxon LA; Wilkoff BL
    Heart Fail Rev; 2012 Nov; 17(6):777-9. PubMed ID: 21814858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 14. ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.
    DeVore AD; Al-Khatib SM
    JACC Heart Fail; 2019 Oct; 7(10):907-910. PubMed ID: 31521688
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac Resynchronization Therapy: How to Decrease Nonresponders.
    Tolosana JM; Mont L
    Heart Fail Clin; 2017 Jan; 13(1):233-240. PubMed ID: 27886928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular endocardial leadless pacing brings new hope to patients with heart failure.
    Wang HX; Li XF; Zhang H; Sun S
    Int J Cardiol; 2013 Aug; 167(3):1073-4. PubMed ID: 23168008
    [No Abstract]   [Full Text] [Related]  

  • 17. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimisation of cardiac resynchronisation therapy device selection guided by cardiac magnetic resonance imaging: Cost-effectiveness analysis.
    Crespo C; Linhart M; Acosta J; Soto-Iglesias D; Martínez M; Jáuregui B; Mira Á; Restovic G; Sagarra J; Auricchio A; Fahn B; Boltyenkov A; Lasalvia L; Sampietro-Colom L; Berruezo A
    Eur J Prev Cardiol; 2020 Apr; 27(6):622-632. PubMed ID: 31487998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
    Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
    Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors for early mortality and arrhythmic events in patients with cardiac resynchronization therapy with defibrillator: A two center cohort study.
    Gunten SV; Theuns DA; Kühne M; Reichlin T; Sticherling C; Schaer B
    Cardiol J; 2019; 26(6):711-716. PubMed ID: 30484267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.